Oxibendazole

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOxibendazole
Drug Alias NameOxibendazoleSK&F-30310
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin beta-2 chain inhibitors
TargetsTubulin beta-2 chain
Therapy Area/IndicationsHelminthiasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHelminthiasis

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG